John Bluth is an accomplished investor relations and corporate communications leader with over 25 years of experience in the biotechnology, pharmaceutical, and energy sectors. Currently serving as the Head of Investor Relations at Jazz Pharmaceuticals plc, Bluth previously held key roles at BioCryst Pharmaceuticals, CV Therapeutics, and PowerSecure, where they significantly enhanced company value and built high-performing teams. Bluth also founded JDB Communications, LLC, a consulting practice in life sciences and clean technology. A Cornell University alumnus with a BA in Biology, Bluth has a proven track record of driving investor understanding and confidence through strategic communications during pivotal company milestones such as IPOs and acquisitions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices